UK markets close in 4 hours 47 minutes

Denali Therapeutics Inc. (DNLI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
16.81+0.65 (+4.02%)
At close: 04:00PM EDT
17.00 +0.19 (+1.13%)
After hours: 06:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-145,224
-145,224
-325,991
-290,581
71,136
Depreciation & amortisation
16,726
16,726
10,383
8,593
8,531
Stock-based compensation
108,102
108,102
99,847
85,247
50,351
Change in working capital
-289,926
-289,926
-24,030
-20,412
288,401
Accounts payable
2,431
2,431
2,274
3,705
-1,623
Other working capital
-370,930
-370,930
-262,549
-219,889
413,057
Other non-cash items
-3,717
-3,717
-3,288
-2,984
-2,322
Net cash provided by operating activities
-357,991
-357,991
-244,716
-211,389
416,152
Cash flows from investing activities
Investments in property, plant and equipment
-12,939
-12,939
-17,833
-8,500
-3,095
Purchases of investments
-1,813,700
-1,813,700
-1,115,040
-1,422,938
-1,285,468
Sales/maturities of investments
2,075,947
2,075,947
991,486
1,409,812
665,357
Net cash used for investing activities
249,308
249,308
-141,387
-21,626
-623,206
Cash flows from financing activities
Common stock issued
0
0
296,215
0
614,094
Net cash used provided by (used for) financing activities
17,820
17,820
310,670
19,348
634,749
Net change in cash
-90,863
-90,863
-75,433
-213,667
427,695
Cash at beginning of period
219,544
219,544
294,977
508,644
80,949
Cash at end of period
128,681
128,681
219,544
294,977
508,644
Free cash flow
Operating cash flow
-357,991
-357,991
-244,716
-211,389
416,152
Capital expenditure
-12,939
-12,939
-17,833
-8,500
-3,095
Free cash flow
-370,930
-370,930
-262,549
-219,889
413,057